Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; The National Forensic Laboratory Information System Collection of Analysis Data, 47523 [2021-18276]

Download as PDF Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices DEPARTMENT OF JUSTICE [OMB Number 1117–0034] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; The National Forensic Laboratory Information System Collection of Analysis Data Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until October 25, 2021. FOR FURTHER INFORMATION CONTACT: If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:54 Aug 24, 2021 Jkt 253001 Overview of This Information Collection NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 1. Type of Information Collection: Revision of a currently approved collection. 2. Title of the Form/Collection: The National Forensic Laboratory Information System Collection of Analysis Data. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: There are no form numbers for the collection. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Forensic Science Laboratory Management. Affected public (Other): None. Abstract: This collection provides the Drug Enforcement Administration (DEA) with a national database on analyzed drug evidence from nonfederal laboratories. Information from this database is combined with the other existing databases to develop more accurate, up-to-date information on abused drugs. This database represents a voluntary, cooperative effort on the part of participating laboratories to provide a centralized source of analyzed drug data. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 2,640 persons annually for this collection at 2.2015 hour per respondent, for an annual burden of 5,812 hours. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates this collection takes 5,812 annual burden hours. If additional information is required, please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. [Notice (21–055)] Dated: August 20, 2021. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2021–18276 Filed 8–24–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 47523 Aerospace Safety Advisory Panel; Meeting. National Aeronautics and Space Administration (NASA). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the National Aeronautics and Space Administration announces a forthcoming meeting of the Aerospace Safety Advisory Panel (ASAP). DATES: Thursday, September 23, 2021, 2:00 p.m. to 3:30 p.m., Eastern Time. ADDRESSES: This will be a virtual meeting via teleconference. FOR FURTHER INFORMATION CONTACT: Ms. Lisa M. Hackley, ASAP Administrative Officer, NASA Headquarters, Washington, DC 20546, (202) 358–1947 or lisa.m.hackley@nasa.gov. SUPPLEMENTARY INFORMATION: The Aerospace Safety Advisory Panel (ASAP) will hold its Fourth Quarterly Meeting for 2021. This discussion is pursuant to carrying out its statutory duties for which the Panel reviews, identifies, evaluates, and advises on those program activities, systems, procedures, and management activities that can contribute to program risk. Priority is given to those programs that involve the safety of human flight. The agenda will include: —Updates on the International Space Station Program —Updates on the Commercial Crew Program —Updates on Exploration System Development Program —Updates on Human Lunar Exploration Program —NASA’s Human Flight Evolution This meeting is a virtual meeting, and only available telephonically. Any interested person may call the USA toll free conference call number 888–566– 6133; passcode 8343253 and then the # sign. At the beginning of the meeting, members of the public may make a verbal presentation to the Panel on the subject of safety in NASA, not to exceed 5 minutes in length. To do so, members of the public must contact Ms. Lisa M. Hackley at lisa.m.hackley@nasa.gov or at (202) 358–1947 at least 48 hours in advance. Any member of the public is permitted to file a written statement with the Panel via electronic submission to Ms. Hackley at the email address previously noted. Verbal presentations and written statements should be SUMMARY: E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18276]



[[Page 47523]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0034]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Revision of a Previously Approved Collection; The 
National Forensic Laboratory Information System Collection of Analysis 
Data

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget for review 
and approval in accordance with the Paperwork Reduction Act of 1995.

DATES: Comments are encouraged and will be accepted for 60 days until 
October 25, 2021.

FOR FURTHER INFORMATION CONTACT: If you have comments, especially on 
the estimated public burden or associated response time, suggestions, 
or need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Diversion Control Division, Drug Enforcement Administration; Mailing 
Address: 8701 Morrissette Drive, Springfield, Virginia 22152; 
Telephone: (571) 362-3261.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Revision of a currently approved 
collection.
    2. Title of the Form/Collection: The National Forensic Laboratory 
Information System Collection of Analysis Data.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: There are no form numbers for 
the collection. The applicable component within the Department of 
Justice is the Drug Enforcement Administration, Diversion Control 
Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Forensic Science Laboratory Management.
    Affected public (Other): None.
    Abstract: This collection provides the Drug Enforcement 
Administration (DEA) with a national database on analyzed drug evidence 
from non-federal laboratories. Information from this database is 
combined with the other existing databases to develop more accurate, 
up-to-date information on abused drugs. This database represents a 
voluntary, cooperative effort on the part of participating laboratories 
to provide a centralized source of analyzed drug data.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 2,640 persons annually for this collection at 2.2015 hour per 
respondent, for an annual burden of 5,812 hours.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates this collection takes 
5,812 annual burden hours.
    If additional information is required, please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: August 20, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2021-18276 Filed 8-24-21; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.